Chimerix Scraps Ebola Drug Trial

Chimerix Inc. scrapped testing of its experimental antiviral in Ebola patients in Liberia, saying the number of infections had dropped in recent weeks, and that only a handful of patients had been enrolled in the Liberian study.



from WSJ.com: US Business http://ift.tt/1BKf7jc

via IFTTT